Global Implantable Drug Delivery Devices Market Research Report

The Global Implantable Drug Delivery Market, mainly driven by a growing prevalence of target disease segments such as Prostate Cancer, diabetic retinopathy, chronic pain causing diseases, cardiovascular diseases, Colorectal Cancer, and a rapid aging global population was valued at $9.05 billion in 2013 and expected to be $12.42 billion by 2018, growing at a CAGR of 6.5%.

 The report “Global Implantable Drug Delivery Market forecast, 2012-2018 “analyzes the market of devices by segments such as Drug eluting stents, Infusion Pumps, Intraocular Implants, Brachytherapy Seeds, Contraceptive Implants.

The North American Implantable drug delivery market held the majority market share. The U.S. is the world’s largest pharmaceuticals market. It is the world leader in biopharmaceutical research; around 80% of the world’s research and development in biotechnology is conducted by U.S.-based firms. According to the Bureau of Labor Statistics, U.S., the pharmaceutical sector employed approximately 272,000 people, and spent $67.4 billion on research and development in 2010. Thus, the well-established U.S. pharmaceutical industry is a favorable factor for growth of the drug delivery market.

The key drivers for the drug delivery market in North America are the robust pharmaceutical industry, large number of pharmaceutical companies and drug delivery technology providers, and increasing number of collaborations and partnerships between technology providers and pharmaceutical companies. In addition, an increased demand for self-administration and home healthcare devices, and increasing applications of inhalers, transdermal patches and Implantable systems for chronic disease areas such as migraine, diabetes, cancer pain, and asthma have boosted the growth of the market. Healthcare reforms in the u.s. will impact the drug delivery market

Europe holds the second position in terms of value of the overall pharmaceutical market. The European pharmaceutical market was worth $228 billion in 2011, accounting for 26.8% of the global pharmaceuticals market. The industry invested Euro 27,500 million in R&D in 2011, provided direct employment to 660,000 Europeans, and generated three to four times more employment indirectly. However, the pharmaceutical markets in major five European countries - Germany, France, U.K., Italy, and Spain - grew at an average rate of 2.6% in 2011, due to the overall current grim economic condition in Europe and increasing competition from emerging nations.

The pharmaceutical markets in India and China are growing rapidly owing to low costs and favorable regulatory environments. The Indian pharmaceutical market was ranked 4th in terms of volume and 15th in terms of value in 2011, and is expected to reach $20 billion by 2015. The Chinese pharmaceutical market was ranked third largest (by value) with size worth $64 billion and is expected to become the second largest by 2015, growing at more than 20% annually.

Asia held a share of 15.0% of the total drug delivery market in 2012 and was worth $21.71 billion. It is poised to grow at a double-digit CAGR of 12.6%, to reach $39.35 billion by 2017. The major factors propelling the Asian market are saturated Western markets and economic downturn in the U.S. and Europe. Furthermore, expansion of the Asian economy, increase in disposable income, development of healthcare infrastructure, increasing penetration of health insurance, and rising prevalence of chronic diseases will drive the growth of the pharmaceutical market. This, in turn, will accelerate the growth of the drug delivery market in Asia.

The report also provides an extensive competitive landscaping of companies operating in Implantable Drug Delivery market. The main companies operating in Implantable Drug Delivery Market are Boston Scientific, Abbott Laboratories, Medtronic, Allergen INC, Merck, Bayer Pharma AG, Arrow International, Theragenics, Varian Medical Systems, and Eckert Ziegler.

Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.

Customization Options:

With Market data, you can also customize MMM assessments that meet your Company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:

Product Analysis

• Usage pattern (in-depth trend analysis) of Implantable Drug Delivery products (Segment wise)
• Product Matrix which gives a detailed comparison of Implantable Drug Delivery product portfolio of each company mapped at country and sub segment level
• End-user Adoption rate analysis of the products (Segment wise and Country wise)
• Comprehensive coverage of Product approvals, Pipeline products and Product recalls

Epidemiology Data

• Country specific Prevalence of Prostate Cancer, Breast and female genital organs Cancers, Lung and pleura Cancers, Head and neck cancers, Colorectal Cancer, Spine Cancer and Brain Cancer
• Country specific Patient pool of Prostate Cancer, Breast and female genital organs Cancers, Lung and pleura Cancers, Head and neck cancers, Colorectal Cancer, Spine Cancer and Brain Cancer
• Disease progression (Pattern analysis)

Pharmacists Forum

• Fast turn-around analysis of Pharmacists response to market events and trends
• Pharmacists opinion about Implantable Drug Delivery products from different companies
• Pharmacists qualitative inputs on epidemiology data
• Pattern analysis of usage of drugs by physicians

Brand/Product Perception Matrix

• Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
• Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)

Pricing Trends

• Cost Analysis of Drug Delivery Implants in Various Countries.
• Prostate Cancer, diabetic retinopathy, Colorectal Cancer, cardiovascular implants procedural investment in major countries.

Competitive Intelligence

• The company share analysis of Implantable Drug Delivery Systems for the top players of the market in the Asia.
• The crucial developments and strategies of companies inculcating in their portfolio for Implantable Drug Delivery Systems.

Please fill in the form below to receive a free copy of the Summary of this Report

* First Name :

* Last Name :

* Designation :

* Company :

* Email(Username) :

* Phone :

* Country :

-- Select Country -- India Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antigua Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia Herzegovina Botswana Brazil British Virgin Island Brunei Darussalam Bulgaria Burkina Faso Burundi Cote d'Ivoire Cambodia Cameroon Canada Cape Verde Cayman Isls Central African Republic Chad Chile China Colombia Comoros Congo Cook Island Costa Rica Croatia Cuba Cyprus Czech Republic Democratic People's Republic of Korea Democratic Republic of the Congo Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Faroe Islands Falkland Islands (Malvinas) Fiji Finl France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenl Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Holy See Honduras Hong Kong Special Administrative Hungary Iceland Indonesia Iran (Islamic Republic of Iran) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Special Administrative Region of China Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia, Federated States of Micronesia Monaco Mongolia Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherland Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Islands Northern Mariana Islands Norway Occupied Palestinian Territory Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Republic of Korea Republic of Moldova Romania Russian Federation Rwa Saint Helena Saint Kitts Nevis Saint Lucia Saint Pierre Miquelon Saint Vincent the Grenadines Samoa San Marino Sao Tome Principe Saudi Arabia Senegal Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa Spain Sri Lanka Sudan Suriname Svalbard Jan Mayen Islands Swazil Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Thailand The former Yugoslav Republic of Macedonia Timor-Leste Togo Tokelau Tonga Trinidad Tobago Tunisia Turkey Turkmenistan Turks Caicos Isls Tuvalu Uga Ukraine United Arab Emirates United Kingdom United Republic of Tanzania United States United States Virgin Isls Uruguay Uzbekistan Vanuatu Venezuela Viet Nam Wallis Futuna Isls Western Sahara Yemen Yugoslavia Zambia Zimbabwe

Comments :

Reports Interested in :Global Implantable Drug Delivery Devices Market Research Report

* Enter the text from the image to the text box :